News about 'voices'

Clinical Research Scientist for the TB Alliance This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Martino Laurenzi Dr. Laurenzi, an expert in clinical development and community health, is a Clinical Research Scientist at the TB Alliance, where his responsibilities...

Professor of Medicine, University of Colorado School of Medicine, Denver, Colorado This video was recorded on November 13, 2009 at Johns Hopkins University. Michael D. Iseman Dr. Michael D. Iseman is a Professor of Medicine in the Divisions of Pulmonary Medicine and Infectious Diseases at the...

www.dcwild.com/mammals.htm In part three of our talk with Dr. Michele Miller , the Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo, an expert on tuberculosis in wildlife populations, we discuss the state of funding to stop TB in wild animals. [...

Professor of Microbiology and Immunology and of Molecular Genetics, Albert Einstein College of Medicine. This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Bill Jacobs Jacobs moved to Albert Einstein College of Medicine in 1985 to become a postdoc with Barry Bloom, who...

Left unchecked, TB could claim up to 90% of lions in a national park Tuberculosis is currently a leading infectious disease in both human and animal populations across the world. Because it is an older disease, it goes under recognized in all groups – especially wildlife. While it may not generate...

Dr. Gyanu Lamichhane is Assistant Professor, Division of Infectious Diseases at the Johns Hopkins University Center for Tuberculosis Research Labs. This interview was conducted at JHU on November 13, 2009. The following bio is excerpted from this bio sketch (.pdf – 80kb) , which includes a list of...

Dr. Michele Miller, Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo When we think of infectious diseases, such as HIV or Tuberculosis , we usually consider them to be a human problem – there are rarely reports of disease in animals, unless it...

Dr. Joel S. Freundlich Dr. Joel S. Freundlich attended Cornell University as a McMullen scholar and an Exxon scholar, attaining his B.S. degree with Distinction in Chemical Engineering in 1991 and his M. Eng. degree in Chemical Engineering in 1992. He received his Ph.D. degree in 1996 in Organic...

Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. For more than half a century, Dr. Mitchison has been dedicated to discovering new treatments for tuberculosis. Recently...

This article originally appeared in Clinical Infectious Diseases 2010;50:S260–S266 © 2010 by the Infectious Diseases Society of America. All rights reserved. 1058-4838/2010/5010S3-0026$15.00 DOI: 10.1086/651500 Mark Harrington is Executive Director of Treatment Action Group Tuberculosis (TB) and...

Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. For more than half a century, Dr. Mitchison has been dedicated to discovering new treatments for tuberculosis. Recently...

Dr. Denis Mitchison in the lab When you think of true pioneers in research and development for the treatment of infectious diseases, Dr. Dennis Mitchison is sure to come to mind. Born on September 6, 1916, Dr. Mitchison has had a long career dedicated to treating tuberculosis. After qualifying in...

Dr. Stewart Cole Stewart Cole helped create the Global Health Institute in 2007. Located at the Ecole polytechnique fédérale de Lausanne (EPFL), will use cutting-edge techniques to seek solutions to tuberculosis, a growing threat worldwide. Dr Cole’s work on tuberculosis, leprosy, AIDS, gas...

FT.com For World TB Day, the Financial Times’ Andrew Jack interviewed various members of the TB community to get their take on a range of topics: Paul Stoffels, head of R&D at Johnson & Johnson , explains why drugs to cope with tuberculosis have been slow to emerge from the pipelines of the...

Dr. Barbara Laughon Dr. Barbara Laughon works in the Office of the Director, Division of Microbiology and Infectious Diseases at the National Institute of Allergy & Infectious Diseases (NIH/NIAID) . She is also a Core Group member of the Working Group on New TB Drugs and is the Candidates...